Beg, Amer A
Moffitt Cancer Center
3 papers on CoChatORCID 0000-0003-3834-774X
Most cited papers
- Verified
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science
NF-κB Signaling PathwaysCell death mechanisms and regulation
Cited by 3,047
- Verified
Non-canonical IKKs, IKKϵ and TBK1, as novel therapeutic targets in the treatment of non-small cell lung cancer
Kim, J.-Y., Beg, A. A., & Haura, E. B. (2013) · Expert Opinion on Therapeutic Targets
NF-κB Signaling PathwaysLung Cancer Treatments and Mutations
Cited by 17
- Verified
Phase II randomized trial of first-line pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC): Final results.
Saltos, A. N., Tanvetyanon, T., Creelan, B. C., Shafique, M. R., Antonia, S. J., Haura, E. B., Zheng, H., Yu, X., Saller, J. J., Viracacha, S., et al. (2023) · Journal of Clinical Oncology
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 9
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free